You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 37 No. 10, October 1980 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Pathologic Findings in Mucopolysaccharidosis Type IIIB (Sanfilippo's Syndrome B)

M. G. Hadfield, MD; N. R. Ghatak, MD; I. Nakoneczna, MD; H. R. Lippman, MD; E. C. Myer, MD; G. Constantopoulos, PhD; R. M. Bradley

Arch Neurol. 1980;37(10):645-650.


Abstract



• The pathologic changes in a rare case of mucopolysaccharidosis (MPS) type IIIB or Sanfilippo's syndrome B (absence of {alpha}-N-acetylglucosaminidase) are presented, along with the biochemical findings. Comparisons were made with other reported cases of MPS III subtypes and related storage disorders in terms of clinical, light microscopic, electron microscopic, and chemical findings, and a correlation of the ultrastructural changes made with the severe neurological dysfunction noted in this disorder. At present, MPS III subtypes cannot be separated from one another by morphological means because the same expression and distribution of lesions may be encountered among differing subtypes.



Author Affiliations



From the Departments of Pathology and Neurology (Drs Hadfield, Ghatak, Nakoneczna, Lippman, and Myer), Medical College of Virginia/ Virginia Commonwealth University, Richmond, and the Developmental and Metabolic Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md (Dr Constantopoulos and Mr Bradley).


Footnotes



Accepted for publication July 31, 1979.

Read before the Eighth International Congress of Neuropathology, Washington, DC, Sept 28, 1978.

Reprint requests to Division of Neuropathology, Box 17, MCV Station, Richmond, VA 23298 (Dr Hadfield).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

GM130 gain-of-function induces cell pathology in a model of lysosomal storage disease
Roy et al.
Hum Mol Genet 2011;0:ddr584v2-ddr584.
ABSTRACT | FULL TEXT  

Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells
Lemonnier et al.
Hum Mol Genet 2011;20:3653-3666.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.